Market Exclusive

WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Results of Operations and Financial Condition

WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition.

On February 16, 2017, West Pharmaceutical Services, Inc. (the
“Company”) issued a press release announcing its fourth-quarter
and full-year 2016>financial results. A copy of the press
release is attached hereto as Exhibit 99.1 and incorporated
herein by reference.
Item 7.01 Regulation FD Disclosure.
The Company also announced that the Board of Directors has
approved a second-quarter 2017 dividend of $0.13 per share. The
dividend will be paid on May 3, 2017, to shareholders of record
as of April 19, 2017.
The information set forth in Item 2.02 Results of Operations and
Financial Condition, including the exhibit referred to therein,
is incorporated herein by reference.
A copy of the Companys presentation materials used during the
call will be available through the Investors link at the Companys
website, http://www.westpharma.com,>and is also attached
hereto as Exhibit 99.2 and incorporated herein by reference.
The information in this report (including the exhibits attached
hereto) is being furnished to Item 2.02 and Item 7.01 and shall
not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (“Exchange Act”), or
otherwise subject to the liabilities of that section, nor will it
be incorporated by reference in any filing under the Securities
Act of 1933, as amended, or the Exchange Act, except as expressly
set forth by specific referencing in such filing.
Item 9.01 Financial Statements and Exhibits.
(d)
Exhibit No.
Description
99.1
West Pharmaceutical Services, Inc. Press Release, dated
February 16, 2017.
99.2
West Pharmaceutical Services, Inc. Presentation Slides.

About WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST)
West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company’s segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions. WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Recent Trading Information
WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) closed its last trading session down -4.37 at 82.59 with 276,405 shares trading hands.

Exit mobile version